Silex Systems Limited
A.C.N. 003 372 067
Level 8, Suite 8.03
56 Clarence Street
Sydney NSW 2000 Australia
PO Box 364
Sydney NSW 2001
Tel: + 61 2 9704 8888
Fax: +61 2 9279 1051 www.silex.com.au
Full Year Financial Results - Investor Conference Call NotificationSilex Systems Limited (ASX: SLX) (OTCQX: SILXY) will release its financial results for the year ended 30th June 2014 on Wednesday, 27th August 2014.
Investors are invited to join a conference call to be hosted by Dr Michael Goldsworthy, CEO/Managing Director at 12.00pm (AEST) on Wednesday, 27th August 2014. An update on the company's current activities will also be provided during the call.
Conference ID: 85486725 Toll free access numbers:Australia | 1800 123 296 |
New Zealand | 0800 452 782 |
China | 4001 203 085 |
Hong Kong | 800 908 865 |
India | 1800 3010 6141 |
Japan | 0120 985 190 |
Singapore | 800 616 2288 |
United Kingdom | 0808 234 0757 |
United States | 1855 293 1544 |
Canada | 1855 561 6766 |
For all other international locations dial*:
*charges apply
+61 2 8038 5221
Further InformationFurther information on the Company's activities can be found on the Silex website: www.silex.com.au or by contacting the persons listed below.
Company | Media and Investor Relations |
Michael Goldsworthy, CEO, or Julie Ducie, CFO / Company Secretary +61 2 9704 8888 | Media: Ben Oliver, Buchan Consulting, +61 3 9866 4722, +61(0)402 242 9825 Investor: Jane Lowe, Buchan Consulting, +61 2 9237 2800 |
1 | P a g e
Forward Looking Statements and Business Risks:
Silex Systems is a research and development Company whose assets are its proprietary rights in various technologies, including, but not limited to, the SILEX technology, Solar Systems technology and business, Translucent technology and ChronoLogic technology. Several of the Company's technologies are in the development stage and have not been commercially deployed, and therefore are high-risk. Accordingly, the statements in this announcement regarding the future of the Company's technologies and commercial prospects are forward looking and actual results could be materially different from those expressed or implied by such forward looking statements as a result of various risk factors.
Some risk factors that could affect future results and commercial prospects include, but are not limited to: results from the SILEX uranium enrichment commercialisation program; the demand for enriched uranium; the risks associated with the development of Solar Systems technology and related marketing activities; the outcomes of the Company's interests in the development of various semiconductor, photonics, instrumentation and alternative energy technologies; the time taken to develop various technologies; the development of competing technologies; the potential for third party claims against the Company's ownership of Intellectual Property associated with its numerous technologies; the potential impact of government regulations or policies; and the outcomes of various commercialisation strategies undertaken by the Company.
2 | P a g e
distributed by |